CoChat
Sign Up
Cited by 36

The DOI matches its Crossref record.

Chitosan-coated Zn-metal-organic framework nanocomposites for effective targeted delivery of LNA-antisense miR-224 to colon tumor: in vitro studies

Mokri, Negin, Sepehri, Zahra, Faninam, Farnaz, Khaleghi, Sepideh, Kazemi, Negar Motakef, Hashemi, Mehrdad·2022·Gene Therapy
DOI 10.1038/s41434-021-00265-7
Open this paper in CoChat — free account

Abstract

Nowadays, nano-compartments are considered as an effective drug delivery system (DDS) for cancer therapy. Targeted delivery of therapeutic agents is an advantageous approach by which cancer cells can be targeted without harming normal cells, and eliminates the negative effects of conventional therapies such as chemotherapy. In this research, a novel zinc-based nanoscale metal-organic framework (Zn-NMOF) coated with folic acid (FA) functionalized chitosan (CS) has been constructed and applied as efficient delivery of LNA (locked nucleic acid)-antisense miR-224 to colon cancer cell lines. LNA-antisense miR-224 as a therapeutic sequence was able to considerably block highly expressed miR-224 and downregulated cancer cell growth. The prepared nano-complex was characterized by analytical devices such as FT-IR, UV-Vis spectrophotometry, DLS, TEM, and XRD. The size range of NMOF-CS-FA-LNA-antisense miR-224 (MCFL224) nano-complex was obtained nearly at 200 nm. The entrapment efficiency of LNA-antisense miR-224 was calculated 72 ± 5% and a significant release profile of LNA-antisense miR-224 was observed at first 6 h (about 50%). Then, in vitro assays were implemented on HCT116 (folic acid receptor-positive colon cancer cell line) and CRL1831 (normal colon cell line) to evaluate the therapeutic efficiency of the MCFL224 nano-complex. In these investigations, decreased cell viability (14.22 ± 0.3% after 72 h treatment), increased apoptotic and autophagy-related genes expression level (…

Overview

Integrity signals

Registry

Crossref · 10.1038/s41434-021-00265-7

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 50

  1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–86. · DOI · Paper page
  2. Narmani A, Kamali M, Panahi Y, Amini B, Salimi A. Targeting delivery of oxaliplatin with smart PEG-modified PAMAM G4 to colorectal cell line: in vitro studies. Process Biochem. 2018;69:178–87. · DOI
  3. Ding S, Khan AI, Cai X, Song Z, Lyu Z, Du D, et al. Overcoming blood-brain barrier transport: advances in nanoparticle-based drug delivery strategies. Mater Today. https://doi.org/10.1016/j.mattod.2020.02.001. · DOI
  4. Narmani A, Farhood B, Haghi-Aminjan H, Mortezazadeh T, Aliasgharzadeh A, Mohseni M, et al. Gadolinium nanoparticles as diagnostic and therapeutic agents: their delivery systems in magnetic resonance imaging and neutron capture therapy. J Drug Deliv Sci Technol. 2018;44:457–66. · DOI
  5. Kumari R, Sunil D, Ningthoujam RS. Hypoxia-responsive nanoparticle based drug delivery systems in cancer therapy: an up-to-date review. J Control Release. 2020;319:135–56. · DOI
  6. Yousefi M, Narmani A, Jafari SM. Dendrimers as efficient nanocarriers for the protection and delivery of bioactive phytochemicals. Adv. Colloid Interface Sci. 2020;278:102125. · DOI
  7. Wu D, Zhu L, Li Y, Zhang X, Xu S, Yang G, et al. Chitosan-based colloidal polyelectrolyte complexes for drug delivery: a review. Carbohydr Polym. 2020;238:116126. · DOI
  8. Narmani A, Kamali M, Amini B, Kooshki H, Amini A, Hassani L. Highly sensitive and accurate detection of Vibrio cholera O1 OmpW gene by fluorescence DNA biosensor based on gold and magnetic nanoparticles. Process Biochem. 2018;65:46–54. · DOI
  9. Wang XG, Dong ZY, Cheng H, Wan SS, Chen WH, Zou MZ, et al. A multifunctional metal–organic framework based tumor targeting drug delivery system for cancer therapy. Nanoscale. 2015;7:16061–70. · DOI
  10. Zhuang J, Kuo CH, Chou LY, Liu DY, Weerapana E, Tsung CK. Optimized metal_organic- framework nanospheres for drug delivery: evaluation of small-molecule encapsulation. ACS Nano. 2014;8:2812–9. · DOI
  11. Liang K, Wang R, Boutter M, Doherty CM, Mulet X, Richardson JJ. Biomimetic mineralization of metal–organic frameworks around polysaccharides. Chem Commun. 2017;19:1249–52. · DOI
  12. Zheng H, Zhang Y, Liu L, Wan W, Guo P, Nystrom AM, et al. One-pot synthesis of metal–organic frameworks with encapsulated target molecules and their applications for controlled drug delivery. J Am Chem Soc. 2016;138:962–8. · DOI
  13. Narmani A, Rezvani M, Farhood B, Darkhor P, Mohammadnejad J, Amini B, et al. Folic acid functionalized nanoparticles as pharmaceutical carriers in drug delivery systems. Drug Dev Res. 2019;80:404–24. · DOI
  14. Narmani A, Mohammadnejad J, Yavari K. Synthesis and evaluation of polyethylene glycol- and folic acid-conjugated polyamidoamine G4 dendrimer as nanocarrier. J Drug Deliv Sci Technol. 2019;50:278–86. · DOI
  15. Narmani A, Arani MAA, Mohammadnejad J, Vaziri AZ, Solymani S, Yavari K, et al. Breast tumor targeting with PAMAM-PEG-5FU-99mTc as a new therapeutic nanocomplex: in in-vitro and in-vivo studies. Biomed Microdevices. 2020;22:31. · DOI
  16. Chen Y, Wu D, Zhong W, Kuang S, Luo Q, Song L, et al. Evaluation of the PEG fensity in the PEGylated chitosan nanoparticles as a drug carrier for curcumin and mitoxantrone. Nanomaterials. 2018;8:486. · DOI
  17. Rezvani M, Mohammadnejad J, Narmani A, Bidaki K. Synthesis and in vitro study of modified chitosan polycaprolactamnanocomplex as delivery system. Int J Biol Macromol. 2018;113:1287–93. · DOI
  18. Mombini S, Mohammadnejad J, Bakhshandeh B, Narmani A, Nourmohammadi J, Vahdat S, et al. Chitosan-PVA-CNT nanofibers as electrically conductive scaffolds for cardiovascular tissue engineering. Int J Biol Macromol. 2019;140:278–87. · DOI
  19. Duan J, Liang X, Cao Y, Wang S, Zhang L. pH-sensitive polymeric micelles for targeted delivery to inflamed joints. Macromolecules. 2015;48:2706–14. · DOI
  20. Jiang YW, Chen LA. microRNAs as tumor inhibitors, oncogenes, biomarkers for drug efficacy and outcome predictors in lung cancer (review). Mol Med Rep. 2012;5:890–4. · DOI
  21. Roldo C, Missiaglia E, Hagan JP, Falconi M, Capelli P, Bersani S, et al. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol. 2006;24:4677–84. · DOI
  22. Liao W-T, Li T-T, Wang Z-G, Wang S-Y, He M-R, Ye Y-P, et al. microRNA-224 promotes cell proliferation and tumor growth in human colorectal cancer by repressing PHLPP1 and PHLPP2. Clin Cancer Res. 2013;19:4662. · DOI
  23. Huang L, Dai T, Lin X, Zhao X, Chen X, Wang C, et al. MicroRNA-224 targets RKIP to control cell invasion and expression of metastasis genes in human breast cancer cells. Biochem Biophys Res Commun. 2012;425:127–33. · DOI
  24. Hidalgo T, Giménez-Marqués M, Bellido E, Avila J, Asensio MC, Salles F, et al. Chitosan-coated mesoporous MIL-100 (Fe) nanoparticles as improved bio-compatible oral nanocarriers. Sci Rep. 2017;7:43099. · DOI
  25. Daryasari MP, Akhgar MR, Mamashli F, Bigdeli B, Khoobi M. Carbon dots embedded magnetic nanoparticles@ chitosan@ metal organic framework as a nanoprobe for pH sensitive targeted anticancer drug delivery. RSC Adv. 2016;107:105578–88. · DOI
  26. Narmani A, Yavari K, Mohammadnejad J. Imaging, biodistribution and in vitro study of smart 99mTc-PAMAM G4 dendrimer as novel nano-complex. Colloids Surf B. 2017;159:232–40. · DOI
  27. Bwatanglang IB, Mohammad F, Yusof NA, Abdullah J, Alitheen NB, Hussein MZ, et al. In vivo tumor targeting and anti-tumor effects of 5-fluororacil loaded, folic acid targeted quantum dot system. J Colloid Interface Sci. 2016;480:146–58. · DOI
  28. Ghaffar I, Imran M, Perveen S, Kanwal T, Saifullah S, Bertino MF. Synthesis of chitosan coated metal organic frameworks (MOFs) for increasing vancomycin bactericidal potentials against resistant S. aureus strain. Mater Sci Eng C. 2019;105:110111. · DOI
  29. Liu L, Ping E, Sun J, Zhang L, Zhou Y, Zhong Y, et al. Multifunctional Ag@ MOF-5@chitosan non-woven cloth composites for sulfur mustard decontamination and hemostasis. Dalton Trans. 2019;48:6951–9. · DOI
  30. Yang L, Ruess GL, Carreon MA. Cu, Al and Ga based metal organic framework catalysts for the decarboxylation of oleic acid. Catal Sci Technol. 2015;5:2777–82. · DOI
  31. Ali MEA, Aboelfadl MMS, Selim AM, Khalil HF, Elkady GM. Chitosan nanoparticles extracted from shrimp shells, application for removal of Fe(II) and Mn(II) from aqueous phases. Sep Sci Technol. 2018;53:2870–81. · DOI
  32. Chalati T, Horcajada P, Gref R, Couvreur P, Serre C. Optimisation of the synthesis of MOF nanoparticles made of flexible porous iron fumarate MIL-88A. J Mater Chem. 2011;21:2220–7. · DOI
  33. Abazari R, Mahjoub AR, Ataei F, Morsali A, Carpenter-Warren CL, Mehdizadeh K, et al. Chitosan immobilization on bio-MOF nanostructures: a biocompatible pH-responsive nanocarrier for doxorubicin release on MCF-7 cell lines of human breast cancer. Inorg Chem. 2018;57:13364–79. · DOI
  34. Hajiashrafi S, Kazemi NM. Preparation and evaluation of ZnO nanoparticles by thermal decomposition of MOF-5. Heliyon. 2019;5:e02152. · DOI
  35. Cosco D, Cilurzo F, Maiuolo J, Federico C, Martino MTD, Cristiano MC. Delivery of miR-34a by chitosan/PLGA nanoplexes for the anticancer treatment of multiple myeloma. Sci Rep. 2015;5:17579. · DOI
  36. Deng X, Cao M, Zhang J, Hu K, Yin Z, Zhou Z, et al. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer. Biomaterials. 2014;35:4333–44. · DOI
  37. Tekie FSM, Atyabi F, Soleimani M, Arefian E, Atashi A, Kiani M, et al. Chitosan polyplex nanoparticle vector for miR-145 expression in MCF-7: optimization by the design of experiment. Int J Biol Macromol. 2015;81:828–37. · DOI
  38. Ju E, Li T, Liu Z, da Silva SR, Wei S, Zhang X, et al. Specific inhibition of viral microRNAs by carbon dots-mediated delivery of locked nucleic acids for therapy of virus-induced cancer. ACS Nano. 2020;14:476–87. · DOI
  39. Lin Q, Mao Y, Song Y, Huang D. MicroRNA-34a induces apoptosis in PC12 cells by reducing B-cell lymphoma 2 and sirtuin-1 expression. Mol Med Rep. 2015;12:5709–14. · DOI
  40. Wu J, Wu G, Lv L, Ren YF, Zhang XJ, Xue YF, et al. MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1. Carcinogenesis. 2012;33:519–28. · DOI
  41. Zou M, Lu N, Hu C, Liu W, Sun Y, Wang X, et al. Beclin 1-mediated autophagy in hepatocellular carcinoma cells: Implication in anticancer efficiency of oroxylin A via inhibition of mTOR signaling. Cell Signal. 2012;24:1722–32. · DOI
  42. Towers CG, Wodetzki D, Thorburn A. Autophagy and cancer: Modulation of cell death pathways and cancer cell adaptations. Journal of Cell Biology. 2020;219:e201907022. · DOI
  43. Levy JM, Thorburn A. Autophagy in cancer: moving from understanding mechanism to improving therapy responses in patients. Cell Death Differ. 2020;27:843–57. · DOI
  44. Murad H, Hawat M, Ekhtiar A, AlJapawe A, Abbas A, Darwish H, et al. Induction of G1-phase cell cycle arrest and apoptosis pathway in MDA-MB-231 human breast cancer cells by sulfated polysaccharide extracted from Laurencia papillosa. Cancer Cell Int. 2016;16:1–1. · DOI
  45. Karsy M, Arslan E, Moy F. Current progress on understanding microRNAs in glioblastoma multiforme. Genes Cancer. 2012;3:3–15. · DOI · Paper page
  46. Tu L, Wang M, Zhao W-Y, Zhang Z-Z, Tang D-F, Zhang Y-Q. miRNA-218-loaded carboxymethyl chitosan-tocopherol nanoparticle to suppress the proliferation of gastrointestinal stromal tumor growth. Mater Sci Eng C. 2017;72:177–84. · DOI
  47. Wang L, Zhou B–B, Yu K, Su Z–H, Gao S, Chu L–L, et al. Novel antitumor agent, Trilacunary Keggin–type tungstobismuthate, inhibits proliferation and induces apoptosis in human gastric cancer SGC–7901 cells. Inorg. Chem. 2013;52:5119–27. · DOI
  48. Howe EN, Cochrane DR, Richer JK. Targets of miR-200c mediate suppression of cell motility and anoikis resistance. Breast Cancer Res. 2011;13:R45. · DOI
  49. Stein CA, Castanotto D. FDA-approved oligonucleotide therapies in 2017. Mol Ther. 2017;25:1069–75. · DOI
  50. Krishna M. From petunias to the present—a review of oligonucleotide therapy. J Clin Epigenet. 2017;3:38. · DOI

Cited by

Sorted by citations

Metadata

Authors
Mokri, N., Sepehri, Z., Faninam, F., Khaleghi, S., Kazemi, N. M., & Hashemi, M.
ORCID
Khaleghi, Sepideh
Venue
Gene Therapy
Publisher
Springer Science and Business Media LLC
Published
2021-06-09
Volume
29
Issue
12
Pages
680-690
ISSN
  • 0969-7128
  • 1476-5462
DOI
10.1038/s41434-021-00265-7
Cited by
36
References
0
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review